ProName: Alarelin
CasNo: 79561-22-1
Molecular Formula: C56H78N16O12
Appearance: White powder
Port: Shenzhen
ProductionCapacity: 5 Kilogram/Month
Purity: Greater than 98.0%
Storage: 2~8℃,protected from light
Transportation: by courier
LimitNum: 0 Metric Ton
professional alarelin manufacturer in china.
high quality with gmp grade
large scale with competitive price
our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.
Alarelin acetate peptide is a single, non-glycosylated polypeptide chain containing 9 amino acids, having a molecular mass of 1167.3 Dalton a Molecular formula of C56H78N16O12 x C2H4O2.
CAS No. is 79561-22-1.
Company Profile:
company name:Shenzhen JYMed Technology Co.,Ltd.
Year Established:2009
Capital: 89.5 Million RMB
Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate, Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,.....
We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis. JYM has successfully submitted a lot of ANDA peptide APIs and formulated products with CFDA and have more than fourty patents approved.
Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.